BioLine RX News

News

Ticker

BLRX.TA

ISIN

IL0011015182

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

BioLine RX Eulerpool News

BioLine RX Stock News

BioLine RX is being monitored by journalists and investors worldwide. We gather the latest BioLine RX news here.

March 20 ·
Benzinga
Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings
February 26 ·
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23 ·
Benzinga
Arbitrator Issues Final Award To BioLineRx, Denies All Claims By Biokine Therapeutics; Biokine To Pay Expenses And Legal Fees
November 29 ·
Yahoo
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
November 25 ·
Yahoo
BLRX: Stem Cell Mobilization Presentation at ASH
November 24 ·
Yahoo
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 24 ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
November 18 ·
Yahoo
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
November 17 ·
Yahoo
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
September 30 ·
Yahoo
BLRX: A Venture into GBM

BioLine RX Stock Press Releases

BioLine RX regularly publishes news on the company's website that are relevant for investors.

BioLine RX News 2026

This page contains all current news, analysis and press releases for BioLine RX stock (BLRX.TA, ISIN: IL0011015182). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at BioLine RX.

BioLine RX Stock

BioLine RX BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe.